The overall goal of this proposed KL2 Program is to facilitate the recruitment, training, mentoring and retention of clinical and translational researchers from a broad range of health professions and diverse backgrounds. The program is designed to address some of the unmet needs and challenges for strengthening the clinical investigator pipeline that were outlined by the NIH Physician-Scientist Workforce working group. Its curricular activities were informed by a survey of the needs of young scientists across the Mount Sinai Health System. The proposed program: 1) takes a comprehensive approach to targeting and selecting KL2 candidates with special emphasis on underrepresented minorities and partnership with department chairs to help ensure retention; 2) provides multidisciplinary mentorship and individual coaching to identify strengths and weaknesses of scholars to inform individual development plans; 3) expands the training experiences outside of the Mount Sinai campus, including industry, community organizations and other CTSA hubs; 4) formalizes the training of research mentors at Mount Sinai and undertakes a concerted effort to expand the ranks of underrepresented minority mentor-role models; 5) emphasizes team sciences through courses that involve team-based technology product development and seminars on team building with management specialists; 6) facilitates transition to individual investigator status through grant writing workshops; and 7) includes the infrastructure for long-term tracking of our trainees to assess the outcomes of our training innovations and our contribution to the research workforce. The proposed KL2 program builds on the rich educational infrastructure and expertise of Mount Sinai and its new educational partner, Rensselaer Polytechnic Institute, which provides, among other things, educational and research collaboration opportunities in engineering and computer science. The proposed program also enriches the experience of scholars through its integration with other components of this CTSA, including Research Expertise and Methods, Research Implementation and Participation and Translational Science Base. Mount Sinai is committed to evolving our already successful KL2 program to optimize the training of translational researchers and believe that we have an important role to play in providing the laboratory for the implementation and assessment of research training innovations that have the potential to more generally shape the future of scientific training and investigation.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
5KL2TR001435-03
Application #
9260956
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Merchant, Carol
Project Start
2015-08-15
Project End
2020-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
$808,545
Indirect Cost
$59,892
Name
Icahn School of Medicine at Mount Sinai
Department
Pediatrics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Berrouiguet, Sofian; Perez-Rodriguez, Mercedes M; Larsen, Mark et al. (2018) From eHealth to iHealth: Transition to Participatory and Personalized Medicine in Mental Health. J Med Internet Res 20:e2
Shameer, Khader; Perez-Rodriguez, M Mercedes; Bachar, Roy et al. (2018) Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining. BMC Med Inform Decis Mak 18:79
Bassir Nia, Anahita; Eveleth, Matthew C; Gabbay, Jonathan M et al. (2018) Past, present, and future of genetic research in borderline personality disorder. Curr Opin Psychol 21:60-68
Altman, Deena R; Sullivan, Mitchell J; Chacko, Kieran I et al. (2018) Genome Plasticity of agr-Defective Staphylococcus aureus during Clinical Infection. Infect Immun 86:
Vora, Anvi K; Fisher, Amanda M; New, Antonia S et al. (2018) Dimensional Traits of Schizotypy Associated With Glycine Receptor GLRA1 Polymorphism: An Exploratory Candidate-Gene Association Study. J Pers Disord 32:421-432
Chacko, Kieran I; Sullivan, Mitchell J; Beckford, Colleen et al. (2018) Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia. Antimicrob Agents Chemother 62:
Roda, G; Narula, N; Pinotti, R et al. (2017) Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther 45:1481-1492
Nitzburg, George C; Cuesta-Diaz, Armando; Ospina, Luz H et al. (2017) Organizational Learning Strategies and Verbal Memory Deficits in Bipolar Disorder. J Int Neuropsychol Soc 23:358-366
Russo, M; Van Rheenen, T E; Shanahan, M et al. (2017) Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings. Psychol Med 47:2892-2905
Burisch, Johan; Ungaro, Ryan; Vind, Ida et al. (2017) Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. J Crohns Colitis 11:1200-1204

Showing the most recent 10 out of 30 publications